SPECPAIR Trademark

Trademark Overview

On Wednesday, March 31, 2021, a trademark application was filed for SPECPAIR with the United States Patent and Trademark Office. The USPTO has given the SPECPAIR trademark a serial number of 90615199. The federal status of this trademark filing is REGISTERED as of Tuesday, January 16, 2024. This trademark is owned by Phanes Therapeutics, Inc.. The SPECPAIR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of antibodies; research and development in the field of antibody drugs; research and development of antibody drugs for the treatment of various diseases including cancer; technical research in the field of antibodies; technology research in the field of antibody research and development; conducting early evaluations in the field of new antibodies; technical research in the field of engineering
specpair

General Information

Serial Number90615199
Word MarkSPECPAIR
Filing DateWednesday, March 31, 2021
Status700 - REGISTERED
Status DateTuesday, January 16, 2024
Registration Number7279821
Registration DateTuesday, January 16, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements

Pseudo MarkSPEC PAIR
Goods and ServicesResearch and development in the field of antibodies; research and development in the field of antibody drugs; research and development of antibody drugs for the treatment of various diseases including cancer; technical research in the field of antibodies; technology research in the field of antibody research and development; conducting early evaluations in the field of new antibodies; technical research in the field of engineering

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 8, 2021
Primary Code042
First Use Anywhere DateSaturday, December 31, 2022
First Use In Commerce DateThursday, March 16, 2023

Trademark Owner History

Party NamePhanes Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NamePhanes Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NamePhanes Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, January 22, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024REGISTERED-PRINCIPAL REGISTER
Thursday, December 14, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, December 13, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 20, 2023ASSIGNED TO LIE
Friday, June 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 25, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 25, 2023NON-FINAL ACTION E-MAILED
Tuesday, April 25, 2023SU - NON-FINAL ACTION - WRITTEN
Thursday, April 6, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 21, 2023USE AMENDMENT FILED
Thursday, April 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 21, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, January 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 24, 2023SOU EXTENSION 2 GRANTED
Tuesday, January 24, 2023SOU EXTENSION 2 FILED
Tuesday, January 24, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 9, 2022SOU EXTENSION 1 GRANTED
Tuesday, August 9, 2022SOU EXTENSION 1 FILED
Tuesday, August 9, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 12, 2021ASSIGNED TO EXAMINER
Thursday, July 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 3, 2021NEW APPLICATION ENTERED

Related Keywords

specpair research field development antibody antibodies technical drugs technology conducting early